Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From NAFLD to MAFLD: Nurse and allied health perspective.
Clayton M, Fabrellas N, Luo J, Alghamdi MG, Hafez A, Qadiri TA, Owise N, Attia D. Clayton M, et al. Among authors: fabrellas n. Liver Int. 2021 Apr;41(4):683-691. doi: 10.1111/liv.14788. Epub 2021 Feb 2. Liver Int. 2021. PMID: 33453067 Review.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Among authors: fabrellas n. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.
Solé C, Ma AT, Solà E, Carol M, Fabrellas N, Juanola A, Napoleone L, Gratacós-Ginès J, Bassegoda O, Cervera M, Pérez M, Rubio AB, Avitabile E, Morales-Ruiz M, Graupera I, Pose E, Kamath PS, Ginès P. Solé C, et al. Among authors: fabrellas n. Liver Int. 2021 Nov;41(11):2729-2732. doi: 10.1111/liv.15069. Epub 2021 Oct 5. Liver Int. 2021. PMID: 34569697
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
Carol M, Pérez-Guasch M, Solà E, Cervera M, Martínez S, Juanola A, Ma AT, Avitabile E, Napoleone L, Pose E, Graupera I, Honrubia M, Korenjak M, Torres F, Ginès P, Fabrellas N; LiverHope Consortium Investigators. Carol M, et al. Among authors: fabrellas n. PLoS One. 2022 Apr 6;17(4):e0265153. doi: 10.1371/journal.pone.0265153. eCollection 2022. PLoS One. 2022. PMID: 35385510 Free PMC article.
Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
Solé C, Solà E, Huelin P, Carol M, Moreira R, Cereijo U, Mas JM, Graupera I, Pose E, Napoleone L, dePrada G, Juanola A, Fabrellas N, Torres F, Morales-Ruiz M, Farrés J, Jiménez W, Ginès P. Solé C, et al. Among authors: fabrellas n. Liver Int. 2019 Jul;39(7):1246-1255. doi: 10.1111/liv.14037. Epub 2019 Feb 17. Liver Int. 2019. PMID: 30597709 Free PMC article.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A; LiverScreen Consortium Investigators. Ginès P, et al. Among authors: fabrellas n. Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10. Hepatology. 2022. PMID: 34537988 Review.
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
Serra-Burriel M, Graupera I, Torán P, Thiele M, Roulot D, Wai-Sun Wong V, Neil Guha I, Fabrellas N, Arslanow A, Expósito C, Hernández R, Lai-Hung Wong G, Harman D, Darwish Murad S, Krag A, Pera G, Angeli P, Galle P, Aithal GP, Caballeria L, Castera L, Ginès P, Lammert F; investigators of the LiverScreen Consortium. Serra-Burriel M, et al. Among authors: fabrellas n. J Hepatol. 2019 Dec;71(6):1141-1151. doi: 10.1016/j.jhep.2019.08.019. Epub 2019 Aug 27. J Hepatol. 2019. PMID: 31470067
Lived Experiences of Hospitalized COVID-19 Patients: A Qualitative Study.
Venturas M, Prats J, Querol E, Zabalegui A, Fabrellas N, Rivera P, Casafont C, Cuzco C, Frías CE, Olivé MC, Pérez-Ortega S. Venturas M, et al. Among authors: fabrellas n. Int J Environ Res Public Health. 2021 Oct 18;18(20):10958. doi: 10.3390/ijerph182010958. Int J Environ Res Public Health. 2021. PMID: 34682704 Free PMC article.
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.
Fabrellas N, Hernández R, Graupera I, Solà E, Ramos P, Martín N, Sáez G, Simón C, Pérez A, Graell T, Larrañaga A, Garcia M, de la Arada A, Juanola A, Coiduras A, Duaso I, Casado A, Martin J, Ginès M, Moreno N, Gema Perez A, Marti L, Bernat M, Sola M, Olivé C, Solé C, Ginès P. Fabrellas N, et al. PLoS One. 2018 Sep 18;13(9):e0200656. doi: 10.1371/journal.pone.0200656. eCollection 2018. PLoS One. 2018. PMID: 30226889 Free PMC article. Clinical Trial.
70 results